Morphine Sulfate
- Product NDC
- 76045-004
- Requested package NDC
- 76045-004-12
- 11-digit product format
- 760450004
- Labeler code
- 76045
- Product ID
- 76045-004_e61f6eb4-cc71-47d3-b2f6-5e689c773779
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine Sulfate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi, USA LLC
- Application
- NDA204223
- Marketing category
- NDA
- Marketing start
- 2013-10-30
- Substance
- MORPHINE SULFATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 76045-004 | 76045-004-12 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 76045-004 | 76045-004-12 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204223-001 | MORPHINE SULFATE | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-002 | MORPHINE SULFATE | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | |
| N204223-003 | MORPHINE SULFATE | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-004 | MORPHINE SULFATE | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | |
| N204223-005 | MORPHINE SULFATE | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | |
| N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | |
| N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | |
| N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | |
| N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-001 | MORPHINE SULFATE | 2MG/ML (2MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-002 | MORPHINE SULFATE | 4MG/ML (4MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-003 | MORPHINE SULFATE | 5MG/ML (5MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-004 | MORPHINE SULFATE | 8MG/ML (8MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD | 2013-10-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204223-005 | MORPHINE SULFATE | 10MG/ML (10MG/ML) | SOLUTION / INTRAMUSCULAR, INTRAVENOUS | RLD, RS | 2013-10-30 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-001 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-002 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-003 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-004 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9072781 | 2034-03-12 | Drug product | 2015-07-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9192608 | 2034-03-12 | U-55 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9192608 | 2034-03-12 | U-43 | 2015-12-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204223-005 | 9248229 | 2034-03-12 | Drug product | 2016-02-17 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Morphine Sulfate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MORPHINE SULFATE | 2 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| X3P646A2J0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1f53de80-efc8-4930-b3e3-fba0d026af05 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76045-004-01 | Morphine Sulfate | 1 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 1 | 7 | |
| 76045-004-11 | Morphine Sulfate | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76045-004-01 | ML - Milliliter | 76045-004 | 1164fa51-463c-4e31-8f12-e3d9c36f3831 | 1 | 2020-05-08 |
| 76045-004-10 | ML - Milliliter | 76045-004 | b199dac9-c7e1-4659-9031-d08feea93598 | 1 | 2014-05-02 |
| 76045-004-11 | ML - Milliliter | 76045-004 | 78da2982-4676-40af-8abb-a4ee58e2ff83 | 1 | 2020-05-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76045-004 | MORPHINE SULFATE (MORPHINE SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 17 | Current NDC, Legacy NDC | 20210310_b62ee1ef-db55-417a-a02e-b103890f9c4b.zip |
| 76045-004 | MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI, USA LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250412_1f53de80-efc8-4930-b3e3-fba0d026af05.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi, USA LLC | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 76045-004 |
| Morphine Sulfate | MORPHINE SULFATE | Fresenius Kabi USA, LLC | 582f42e5-444e-4246-af8c-e7e28097c69a | 2026-07-31 | Boxed warning, Warnings, Adverse reactions | 204223 NDA204223 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 894912 | morphine sulfate 10 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | morphine sulfate 2 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | morphine sulfate 4 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | morphine sulfate 5 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | morphine sulfate 8 MG in 1 ML Prefilled Syringe | PSN | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | 1 ML morphine sulfate 10 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | 1 ML morphine sulfate 2 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | 1 ML morphine sulfate 4 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | 1 ML morphine sulfate 5 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | 1 ML morphine sulfate 8 MG/ML Prefilled Syringe | SCD | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | 1 ML MS 10 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | 1 ML MS 2 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | 1 ML MS 4 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | 1 ML MS 5 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | 1 ML MS 8 MG/ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894912 | morphine sulfate 10 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998212 | morphine sulfate 2 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 998213 | morphine sulfate 4 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 1442790 | morphine sulfate 5 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
| 894914 | morphine sulfate 8 MG per 1 ML Prefilled Syringe | SY | 1f53de80-efc8-4930-b3e3-fba0d026af05 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 76045-004-12 | 76045000412 | 24 BLISTER PACK in 1 CARTON (76045-004-12) > 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-004-02) > 1 mL in 1 SYRINGE, GLASS | 24 blister pack | 2020-09-11 | 0000-00-00 | No | No | Current |